Trial intelligence / Profile preview

Remimazolam vs Propofol for Sedation in Upper GI Endoscopy

NCT03425474Phase 3Completed

Sponsor
Hengrui
Start
Sep 2017
Primary completion
Nov 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of remimazolam in Procedural sedation (PS), sponsored by Hengrui. Started Sep 2017; status: completed.

02

Drugs

remimazolam
03

Conditions

Procedural sedation (PS)

Beyond the preview

Go deeper on NCT03425474.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03425474.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call